InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Anish Bhatnagar, Chairman & CEO. Director active across 1 companies, notably Soleno Therapeutics INC. In total, 3 reports have been logged. Total volume traded: €26k. The latest transaction was filed on 21 January 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
60,000 shares
Common Stock
SEC:0000899243-22-013312:0·
Ideal exit: 26 Dec 2022 (T+270)
€12,86939,033 shares@ €0.32970.0005% mcap100.0% of flow
Common Stock
SEC:0000899243-22-003186·
€12,86939,033 shares@ €0.32970.0005% mcap50.0% of flow
Common Stock
SEC:0000899243-22-003186:0·
3 of 3 declarations
About Anish Bhatnagar
Anish Bhatnagar is the Chief Executive Officer of Soleno Therapeutics Inc. He leads the company in developing innovative treatments for rare diseases. Under his leadership, Soleno Therapeutics is committed to improving patients' lives through advanced therapeutic solutions and cutting-edge research.
